References
- Bangham, A. D., Horne, R. W. (1964). Negative staining of phospholipids and their structural modification by surface active agents as observed in the electron microscope. J Mol Biol 8:660–668.
- Brandl, M. (2003). Liposomal drug carriers for cancer diagnosis and therapy. In: Budman, D. R., Calvert, A. H., Rowinsky, E. K. (Eds.), Handbook of anticancer drug development (pp 225–237). Philadelphia, Pennsylvania, USA: Lippincott Williams & Wilkins.
- Brouwers, J., Brewster, M. E., Augustijns, P. (2009). Supersaturating drug delivery system: the answer to solubility-limited oral bioavailability? J Pharm Sci 98:2549–2572.
- Drummond, D. C., Meyer, O., Hong, K., et al. (1999). Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 5:691–743.
- Frantzen, C. B., Ingebrigtsen, L., Skar, M., Brandl, M. (2003). Assessing the accuracy of routine photon correlation spectroscopy analysis of heterogeneous size distributions. AAPS PharmSciTech [online]. Available at: http://www.springerlink.com/content/a7v263809141313x. Last date of access: August 10th 2010.
- Gabizon, A., Papahadjopoulos, D. (1988). Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A 85:6949–6953.
- Grohganz, H., Ziroli, V., Massing, U., Brandl, M. (2003). Quantification of various phosphatidylcholines in liposomes by enzymatic assay. AAPS PharmSciTech [online]. Available at: http://www.aapspharmscitech.org/articles/pt0404/pt040463/pt040463. Last date of access: August 2010.
- Gulati, M., Grover, M., Singh, S., Singh, M. (1997). Lipophilic drug derivatives in liposomes. Int J Pharm 165:129–168.
- Hradil, P., Hlaváč J., Soural M., et al (2009). 3-Hydroxy-2-phenyl-4(1H)-quinolinones as promising biologically active compounds. Mini Rev Med Chem, 9: 696–702.
- Sætern, A. M., Flaten, G. E., Brandl, M. (2004). A method to determine the incorporation capacity of camptothecin in liposomes. AAPS PharmSciTech [online]. Available at: http://www.springerlink.com/content/c83715622732v278/fulltext. Last date of access: August 2010.
- Schwendener, R., Schott, H. (2010). Liposome formulations of hydrophobic drugs. Meth Mol Biol 605:129–138.
- Soural, M., Hlavác, J., Hradil, P., et al. (2006). 3-hydroxy-2-phenyl-4(1H)-quinolinones as promising biologically active compounds. Eur J Med Chem 41:467–474.